A100120 Stock Overview
Vieworks Co., Ltd. develops, manufactures, and sells imaging systems and solutions.
Price History & Performance
|Historical stock prices|
|Current Share Price||₩40,650.00|
|52 Week High||₩46,650.00|
|52 Week Low||₩34,700.00|
|1 Month Change||-0.37%|
|3 Month Change||5.18%|
|1 Year Change||9.42%|
|3 Year Change||29.67%|
|5 Year Change||-27.41%|
|Change since IPO||194.57%|
Recent News & Updates
|A100120||KR Medical Equipment||KR Market|
Return vs Industry: A100120 exceeded the KR Medical Equipment industry which returned -5.8% over the past year.
Return vs Market: A100120 exceeded the KR Market which returned -14.2% over the past year.
|A100120 Average Weekly Movement||4.4%|
|Medical Equipment Industry Average Movement||5.8%|
|Market Average Movement||5.5%|
|10% most volatile stocks in KR Market||10.4%|
|10% least volatile stocks in KR Market||3.2%|
Stable Share Price: A100120 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: A100120's weekly volatility (4%) has been stable over the past year.
About the Company
Vieworks Co., Ltd. develops, manufactures, and sells imaging systems and solutions. The company offers X-ray detectors and image processing technologies for general radiography system, dental and surgical C-arm systems, radiography and fluoroscopy system, veterinary radiography system, industrial inspection instrument, and other applications. It also provides industrial cameras; and bio imaging systems comprising in vivo imaging systems under the VISQUE brand.
Vieworks Fundamentals Summary
|A100120 fundamental statistics|
Is A100120 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A100120 income statement (TTM)|
|Cost of Revenue||₩97.74b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||3.65k|
|Net Profit Margin||17.33%|
How did A100120 perform over the long term?See historical performance and comparison
1.8%Current Dividend Yield
Is Vieworks undervalued compared to its fair value and its price relative to the market?
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: A100120 (₩40650) is trading below our estimate of fair value (₩120373.46)
Significantly Below Fair Value: A100120 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: A100120 is good value based on its PE Ratio (11.2x) compared to the KR Medical Equipment industry average (13.5x).
PE vs Market: A100120 is good value based on its PE Ratio (11.2x) compared to the KR market (14.1x).
Price to Earnings Growth Ratio
PEG Ratio: A100120 is poor value based on its PEG Ratio (1.5x)
Price to Book Ratio
PB vs Industry: A100120 is good value based on its PB Ratio (2x) compared to the KR Medical Equipment industry average (2.4x).
How is Vieworks forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A100120's forecast earnings growth (7.5% per year) is above the savings rate (3.5%).
Earnings vs Market: A100120's earnings (7.5% per year) are forecast to grow slower than the KR market (14.9% per year).
High Growth Earnings: A100120's earnings are forecast to grow, but not significantly.
Revenue vs Market: A100120's revenue (9.6% per year) is forecast to grow slower than the KR market (9.8% per year).
High Growth Revenue: A100120's revenue (9.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A100120's Return on Equity is forecast to be low in 3 years time (15.9%).
How has Vieworks performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A100120 has high quality earnings.
Growing Profit Margin: A100120's current net profit margins (17.3%) are higher than last year (14.3%).
Past Earnings Growth Analysis
Earnings Trend: A100120's earnings have grown by 2.7% per year over the past 5 years.
Accelerating Growth: A100120's earnings growth over the past year (46.2%) exceeds its 5-year average (2.7% per year).
Earnings vs Industry: A100120 earnings growth over the past year (46.2%) exceeded the Medical Equipment industry 17.9%.
Return on Equity
High ROE: A100120's Return on Equity (17.8%) is considered low.
How is Vieworks's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: A100120's short term assets (₩156.7B) exceed its short term liabilities (₩49.6B).
Long Term Liabilities: A100120's short term assets (₩156.7B) exceed its long term liabilities (₩3.0B).
Debt to Equity History and Analysis
Debt Level: A100120 has more cash than its total debt.
Reducing Debt: A100120's debt to equity ratio has increased from 1.6% to 11.2% over the past 5 years.
Debt Coverage: A100120's debt is well covered by operating cash flow (76.8%).
Interest Coverage: A100120's interest payments on its debt are well covered by EBIT (119.9x coverage).
What is Vieworks's current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: A100120's dividend (1.85%) is higher than the bottom 25% of dividend payers in the KR market (0.85%).
High Dividend: A100120's dividend (1.85%) is low compared to the top 25% of dividend payers in the KR market (2.75%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, A100120 has been paying a dividend for less than 10 years.
Growing Dividend: A100120's dividend payments have increased, but the company has only paid a dividend for 3 years.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (21%), A100120's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (69.1%), A100120's dividend payments are covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Hooshik Kim (57 yo)
Mr. Hooshik Kim has been the Chief Executive Officer and Director of Vieworks Co. Ltd since February 2003. Mr. Kim served as Senior Research Engineer of Samsung Aerospace Industries from January 1990 to Ap...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Vieworks Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Vieworks Co., Ltd.
- Ticker: A100120
- Exchange: KOSDAQ
- Founded: 1999
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: ₩373.245b
- Shares outstanding: 9.18m
- Website: https://www.vieworks.com
Number of Employees
- Vieworks Co., Ltd.
- 41-3, Burim-ro
- 170 beon-gil
- South Korea
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/22 00:00|
|End of Day Share Price||2022/05/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.